You are currently viewing a new version of our website. To view the old version click .

Biomedicines, Volume 2, Issue 4

December 2014 - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Article
  • Open Access
6 Citations
7,237 Views
19 Pages

9 December 2014

Signaling from the c-Met receptor tyrosine kinase is associated with progression and metastasis of epithelial tumors. c-Met, the receptor for hepatocyte growth factor, triggers epithelial-mesenchymal transition (EMT) of cultured cells, which is thoug...

  • Review
  • Open Access
14 Citations
10,544 Views
25 Pages

3 December 2014

Monoclonal antibodies can be seen as valuable tools for many aspects of basic as well as applied sciences. In the case of MET/HGFR, they allowed the identification of truncated isoforms of the receptor, as well as the dissection of different epitopes...

  • Review
  • Open Access
34 Citations
7,194 Views
14 Pages

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer

  • Carminia Maria Della Corte,
  • Morena Fasano,
  • Federica Papaccio,
  • Fortunato Ciardiello and
  • Floriana Morgillo

25 November 2014

The Hepatocyte growth factor (HGF)—mesenchymal-epithelial transition (MET) pathway is deregulated in several cancers and is associated with aggressive phenotype and worse prognosis. MET, a tyrosine kinase receptor activated by HGF, plays a physiolog...

  • Review
  • Open Access
15 Citations
11,612 Views
18 Pages

HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis

  • Giovanni Gaudino,
  • Haining Yang and
  • Michele Carbone

14 November 2014

Malignant mesothelioma (MM) is a highly aggressive cancer related to asbestos or erionite exposure and resistant to current therapies. Hepatocyte Growth Factor (HGF) and its tyrosine kinase receptor Met regulate cell growth, survival, motility/migrat...

  • Review
  • Open Access
42 Citations
7,238 Views
26 Pages

Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling

  • Ognoon Mungunsukh,
  • Elizabeth A. McCart and
  • Regina M. Day

5 November 2014

Hepatocyte growth factor (HGF), also known as scatter factor (SF), is a pleotropic factor required for normal organ development during embryogenesis. In the adult, basal expression of HGF maintains tissue homeostasis and is up-regulated in response t...

  • Review
  • Open Access
84 Citations
14,985 Views
26 Pages

HGF–Met Pathway in Regeneration and Drug Discovery

  • Kunio Matsumoto,
  • Hiroshi Funakoshi,
  • Hisaaki Takahashi and
  • Katsuya Sakai

31 October 2014

Hepatocyte growth factor (HGF) is composed of an α-chain and a β-chain, and these chains contain four kringle domains and a serine protease-like structure, respectively. Activation of the HGF–Met pathway evokes dynamic biological responses that supp...

  • Review
  • Open Access
16 Citations
7,848 Views
12 Pages

24 October 2014

The MET oncogene encodes for Met protein, a trans-membrane tyrosine kinase identified as the high affinity receptor for hepatocyte growth factor (HGF). Immunohistochemical studies have demonstrated that Met protein is intensely expressed in tumor ce...

  • Review
  • Open Access
41 Citations
13,896 Views
16 Pages

HGF/Met Axis in Heart Function and Cardioprotection

  • Simona Gallo,
  • Valentina Sala,
  • Stefano Gatti and
  • Tiziana Crepaldi

21 October 2014

Hepatocyte growth factor (HGF) and its tyrosine kinase receptor (Met) play important roles in myocardial function both in physiological and pathological situations. In the developing heart, HGF influences cardiomyocyte proliferation and differentiat...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059